SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-22-005227
Filing Date
2022-03-31
Accepted
2022-03-31 16:42:15
Documents
87
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K cala-20211231.htm   iXBRL 10-K 3558553
2 EX-23.1 cala-ex23_1.htm EX-23.1 4691
3 EX-31.1 cala-ex31_1.htm EX-31.1 15211
4 EX-31.2 cala-ex31_2.htm EX-31.2 15167
5 EX-32.1 cala-ex32_1.htm EX-32.1 10353
6 EX-32.2 cala-ex32_2.htm EX-32.2 10349
7 GRAPHIC img76786934_0.jpg GRAPHIC 210083
  Complete submission text file 0000950170-22-005227.txt   12751371

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cala-20211231.xsd EX-101.SCH 71702
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cala-20211231_lab.xml EX-101.LAB 610627
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cala-20211231_cal.xml EX-101.CAL 54729
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cala-20211231_pre.xml EX-101.PRE 477201
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cala-20211231_def.xml EX-101.DEF 276749
81 EXTRACTED XBRL INSTANCE DOCUMENT cala-20211231_htm.xml XML 2297620
Mailing Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080 650-870-1000
Calithera Biosciences, Inc. (Filer) CIK: 0001496671 (see all company filings)

IRS No.: 272366329 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36644 | Film No.: 22793421
SIC: 2834 Pharmaceutical Preparations